1. Home
  2. OPTX vs IMUX Comparison

OPTX vs IMUX Comparison

Compare OPTX & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTX
  • IMUX
  • Stock Information
  • Founded
  • OPTX 1981
  • IMUX 2016
  • Country
  • OPTX United States
  • IMUX United States
  • Employees
  • OPTX N/A
  • IMUX N/A
  • Industry
  • OPTX Blank Checks
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OPTX Finance
  • IMUX Health Care
  • Exchange
  • OPTX Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • OPTX 98.6M
  • IMUX 92.2M
  • IPO Year
  • OPTX N/A
  • IMUX N/A
  • Fundamental
  • Price
  • OPTX $2.37
  • IMUX $0.72
  • Analyst Decision
  • OPTX
  • IMUX Strong Buy
  • Analyst Count
  • OPTX 0
  • IMUX 5
  • Target Price
  • OPTX N/A
  • IMUX $7.00
  • AVG Volume (30 Days)
  • OPTX 239.3K
  • IMUX 1.4M
  • Earning Date
  • OPTX 11-14-2025
  • IMUX 11-06-2025
  • Dividend Yield
  • OPTX N/A
  • IMUX N/A
  • EPS Growth
  • OPTX N/A
  • IMUX N/A
  • EPS
  • OPTX N/A
  • IMUX N/A
  • Revenue
  • OPTX $28,816,530.00
  • IMUX N/A
  • Revenue This Year
  • OPTX N/A
  • IMUX N/A
  • Revenue Next Year
  • OPTX N/A
  • IMUX N/A
  • P/E Ratio
  • OPTX N/A
  • IMUX N/A
  • Revenue Growth
  • OPTX 2.45
  • IMUX N/A
  • 52 Week Low
  • OPTX $0.85
  • IMUX $0.56
  • 52 Week High
  • OPTX $5.10
  • IMUX $1.42
  • Technical
  • Relative Strength Index (RSI)
  • OPTX 50.73
  • IMUX 37.30
  • Support Level
  • OPTX $2.40
  • IMUX $0.67
  • Resistance Level
  • OPTX $3.05
  • IMUX $0.87
  • Average True Range (ATR)
  • OPTX 0.33
  • IMUX 0.05
  • MACD
  • OPTX -0.05
  • IMUX -0.01
  • Stochastic Oscillator
  • OPTX 23.38
  • IMUX 26.43

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: